Pharmesis International Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	70.98	67.65	45.64	50.37	52.77	47.11
Revenue Growth (YoY)	69.75%	48.24%	-9.40%	-4.55%	12.01%	26.63%
Cost of Revenue	45.19	43.5	24.82	26.36	27.77	23.25
Gross Profit	25.79	24.15	20.82	24.01	25	23.86
Selling, General & Admin	22.31	22.13	23.61	26.54	23.94	28.18
Operating Expenses	22.24	22.13	23.61	26.54	23.94	28.18
Operating Income	3.55	2.02	-2.8	-2.53	1.06	-4.32
Interest Expense	-0.7	-0.7	-0.87	-0.94	-1.04	-0.92
Interest & Investment Income	0.03	0	0.02	0.03	0.03	0.04
Currency Exchange Gain (Loss)	0	0	0.05	-	-	-
Other Non Operating Income (Expenses)	0.19	0.19	-1.26	0.28	2.06	0.55
EBT Excluding Unusual Items	3.07	1.53	-4.86	-3.16	2.12	-4.65
Asset Writedown	6.91	6.91	-	-	-	-1.34
Other Unusual Items	-	-	-	-	-	0.16
Pretax Income	9.98	8.44	-4.86	-3.16	2.12	-5.84
Income Tax Expense	-0.27	0.83	0.05	0.02	0.15	0.01
Earnings From Continuing Operations	10.25	7.61	-4.9	-3.18	1.97	-5.85
Minority Interest in Earnings	0.14	0.67	-0.05	-0.38	-0.8	0.02
Net Income	10.39	8.28	-4.96	-3.56	1.17	-5.83
Net Income to Common	10.39	8.28	-4.96	-3.56	1.17	-5.83
Shares Outstanding (Basic)	32	30	26	23	23	23
Shares Outstanding (Diluted)	32	30	26	23	23	23
Shares Change (YoY)	14.03%	13.08%	14.85%	-	-	-
EPS (Basic)	0.33	0.28	-0.19	-0.15	0.05	-0.25
EPS (Diluted)	0.33	0.28	-0.19	-0.15	0.05	-0.25
Free Cash Flow	3.47	-4.24	-12.17	6.33	-0.93	0.77
Free Cash Flow Per Share	0.11	-0.14	-0.46	0.28	-0.04	0.03
Gross Margin	36.34%	35.70%	45.61%	47.67%	47.38%	50.64%
Operating Margin	5.00%	2.99%	-6.13%	-5.02%	2.01%	-9.17%
Profit Margin	14.64%	12.24%	-10.86%	-7.07%	2.22%	-12.37%
Free Cash Flow Margin	4.89%	-6.26%	-26.66%	12.56%	-1.76%	1.64%
EBITDA	5.27	3.24	-1.62	-1.19	2.33	-3
EBITDA Margin	7.42%	4.78%	-3.54%	-2.36%	4.42%	-6.37%
D&A For EBITDA	1.72	1.21	1.18	1.34	1.27	1.32
EBIT	3.55	2.02	-2.8	-2.53	1.06	-4.32
EBIT Margin	5.00%	2.99%	-6.13%	-5.02%	2.01%	-9.17%
Effective Tax Rate	-	9.80%	-	-	7.04%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.